Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Activa Alternative In Waiting? ANS Taps Deep Brain Stim, Spinal Drug Delivery

This article was originally published in The Gray Sheet

Executive Summary

Advanced Neuromodulation Systems' deep-brain stimulation device to treat Parkinsonian tremor, nearing pivotal trials, should feature a smaller size and broader programming parameters than Medtronic's Activa DBS, according to the firm

You may also be interested in...



ANS “Ready” For Neuro-Stimulating Competition With Advanced Bionics

Advanced Neuromodulation Systems is girding for Boston Scientific subsidiary Advanced Bionics' full-scale launch of the Precision rechargeable spinal cord stimulator, expecting to be without a competing rechargeable system until 2005

ANS “Ready” For Neuro-Stimulating Competition With Advanced Bionics

Advanced Neuromodulation Systems is girding for Boston Scientific subsidiary Advanced Bionics' full-scale launch of the Precision rechargeable spinal cord stimulator, expecting to be without a competing rechargeable system until 2005

Bard Vascular Unit To Do Heavy Lifting As Hernia Sales Growth Slows

Bard is reevaluating its programmable pain pump strategy due to developmental delays caused by imaging technology compatibility issues

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT019062

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel